Furthermore, tumor cells can enhance PD‐L1 expression by activating signaling pathways such as JAK/STAT, PI3K/AKT, and MAPK in response to inflammatory factors like IFN‐γ or internal genetic alterations within the TME.229. The gene discussed is CD274; the disease is neoplasm.